Resolor – The importance of treatment adherence
This treatment adherence background information document has been prepared by Shire Pharmaceuticals and is for medical media only Non-adherence is a widespread, global problem in patients suffering from chronic diseases and in developed countries adherence averages only 50%.1
Full Time Regulatory Affairs & Pharmacovigilance Officer
Vivian Corporation is an established leader in the marketing of diverse brands which are driven with one unifying goal, to improve the quality of life by creating better opportunities for our customers, patients and consumers alike.
Omega-3 and sleep: New insights from the DHA Oxford Learning and Behaviour (DOLAB) study
Does dietary intake of omega-3 DHA influence children’s sleep?
Wilfred Gatt Charity Cup 2015
The Wilfred Gatt Charity Cup embraces family values, charity, sport and friendship every year on the 19th of March. This is the date of the demise of our much loved Grandfather, Father and Founder of Vivian Corporation – Wilfred Gatt.
Open Breathe Close – Salamol Easi-breathe® in Malta
Teva Pharmaceuticals, in collaboration with Vivian Corporation, are pleased to announce the launch of Salamol Easi-breathe®, a breath-actuated inhaler device, for the relief of acute asthma symptoms including wheezing, breathlessness and tightness of the chest, or before allergen exposure or exercise, in children, adolescents and…
Treatment with Pradaxa® associated with better patient outcomes after a major bleeding event compared to warfarin
Results from a new post-hoc analysis of the landmark RE-LY®i trial show that in patients experiencing a major bleeding event, treatment with Pradaxa® (dabigatran etexilate) was associated with lower mortality and a shorter length of stay in intensive care compared to warfarin.
The importance of treatment adherence
Non-adherence is a widespread, global problem in patients suffering from chronic diseases and in developed countries adherence averages only 50%.1
Resolor® is now available in Malta.
A new treatment option for chronic constipation in women in whom laxatives have failed Malta, 15th June 2012 – Vivian Corporation, local partners of Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that Resolor® (prucalopride) is now available in Malta and…
Efamol study Omega-3 and executive function decline
High Omega-3 Status reduces brain white matter lesions associated with Cognitive Decline 1.
EPO Proven Again to Improve Atopic Eczema
Independent Studies Proving Once Again that EPO Significantly Improves Symptoms of Atopic Eczema 1.